Abstract:Background: As a multifaceted metabolic disorder, insulin resistance is accompanied by the preceding onset of type 2 diabetes mellitus, hyperinsulinemia, metabolic dysfunction-associated fatty liver disease (MAFLD) and other metabolic syndromes. Currently, the number of existing drugs and mechanism-based strategies is limited to alleviate insulin resistance in clinics. As a natural polyphenol product derivative, 1,3,6,7-tetrapropylene acyloxy-ketone (TPX) showed a significant hypoglycemic effect in our previous studies. However, whether TPX could improve hepatic insulin sensitivity was unknown. Purpose: To explore whether insulin sensitivity can be improved by the treatment with TPX and further investigate its mechanism(s) of activity. Methods: To mimic hyperglycemia and insulin resistance in vitro, human HepG2 and HL-7702 hepatocytes were exposed to high glucose. Cellular glucose uptake, glucose consumption, glycogen synthesis, and glucose production were quantified after TPX treatment. The effects of TPX on AMP-activated protein kinase (AMPK) phosphorylation, glucose metabolism, and insulin signal transduction were evaluated by western blotting and network pharmacology analysis. The eGFP-membrane of glucose transporter type 4 (GLUT4) lentivirus transfected cells were constructed to investigate the effects of TPX on GLUT4 mobilization. Reactive oxygen species activity in high glucose-induced insulin-resistant cells was measured by DCFH-DA to show oxidative stress. Results: Treatment with TPX improved glycogen synthesis and inhibited gluconeogenesis by regulating GSK3β, G6Pase, and PEPCK. Furthermore, high glucose-induced inhibition of glucose consumption, glucose uptake, and GLUT4-mediated membrane translocation were reverted by TPX. Accordingly, mechanistic investigations revealed that TPX interacted with AMPK protein and activated the phosphorylation of AKT, thereby improving energy homeostasis and further ameliorating hepatic insulin resistance. Network pharmacology analysis and molecular docking further confirmed AMPK as an active target of TPX. Concordantly, the pharmacological activity of TPX was reversed by the AMPK inhibitor compound C when hepatocytes were exposed to high glucose stimulation. Conclusion: In summary, our study confirmed TPX contributions to insulin resistance improvements by targeting AMPK and PI3K/AKT to restore the insulin signaling pathway, which may be an important potential treatment strategy for insulin-resistance-related diseases, including MAFLD and diabetes.

Abstract 5447: Thromboxane A 2 Receptor Activation Attenuates Insulin Signaling and Angiogenesis by Upregulating Phosphatase PTEN in Cultured Endothelial Cells

Activation of thromboxane A2 receptors mediates endothelial dysfunction in diabetic mice.

Thymosin 4 Promotes Glucose-Impaired Endothelial Progenitor Cell Function Via Akt/Endothelial Nitric Oxide Synthesis Signaling Pathway

Tectorigenin Attenuates Palmitate-Induced Endothelial Insulin Resistance Via Targeting Ros-Associated Inflammation And Irs-1 Pathway

Ameliorative effects of mangiferin derivative TPX on insulin resistance via PI3K/AKT and AMPK signaling pathways in human HepG2 and HL-7702 hepatocytes

Pharmacological Activation of PPAR Gamma Ameliorates Vascular Endothelial Insulin Resistance Via a Non-Canonical PPAR Gamma-Dependent Nuclear Factor-Kappa B Trans-Repression Pathway.

Up-regulation of PTEN (Phosphatase and Tensin Homolog Deleted on Chromosome Ten) Mediates p38 MAPK Stress Signal-induced Inhibition of Insulin Signaling: A CROSS-TALK BETWEEN STRESS SIGNALING AND INSULIN SIGNALING IN RESISTIN-TREATED HUMAN ENDOTHELIAL CELLS

Mechanisms Related to No-Induced Motility in Differentiated Rat Aortic Smooth Muscle Cells

Irtks Promotes Insulin Signaling Transduction Through Inhibiting Ship2 Phosphatase Activity

Inhibiting Protein Tyrosine Phosphatase 1B to Improve Regenerative Functions of Endothelial Cells

Diet induced insulin resistance is due to induction of PTEN expression

Akt Activation: A Potential Strategy to Ameliorate Insulin Resistance.

Protein tyrosine phosphatase 1B inhibition improves endoplasmic reticulum stress‑impaired endothelial cell angiogenic response: A critical role for cell survival

PRDX1 is Involved in Palmitate Induced Insulin Resistance Via Regulating the Activity of P38mapk in HepG2 Cells

Proteomics Identifies Thymidine Phosphorylase As A Key Regulator Of The Angiogenic Potential Of Colony Forming Units And Endothelial Progenitor Cell Cultures

Targeting VE-PTP phosphatase protects the kidney from diabetic injury

Effects of Small Interference RNA Against PTP1B and TCPTP on Insulin Signaling Pathway in Mouse Liver: Evidence for Non-Synergetic Cooperation.

Identification and Modulation of A Caveolae-Dependent Signal Pathway That Regulates Plasminogen Activator Inhibitor-1 in Insulin-Resistant Adipocytes

Insulin-stimulated Hydrogen Peroxide Reversibly Inhibits Protein-tyrosine Phosphatase 1B in Vivo and Enhances the Early Insulin Action Cascade*

Insulin Antagonizes Thrombin-Induced Microvessel Leakage

Regulatory T Cells Promote Apelin-Mediated Sprouting Angiogenesis in Type 2 Diabetes